Westminster has ruled out supporting safe drug consumption rooms across Britain, despite Scotland’s pilot facility operating in Glasgow. Dame Diana Johnson, minister for policing and crime prevention, told MPs that UK drug policy will not include supervised injection sites.

Government Rejects Expansion of Consumption Rooms

Speaking to the House of Commons Scottish Affairs Committee on 4 June, Johnson was unequivocal about the government’s position. “I really want to be clear with you: we do not support drug consumption facilities. It is not our policy and we will not be amending the Misuse of Drugs Act.”

The minister stressed that Scotland’s Thistle facility operates outside Westminster’s legal framework. “This is not a UK government policy. It is something that the Scottish government have decided to do but it does not have legal basis within the Misuse of Drugs Act,” she explained.

Instead, Johnson highlighted alternative approaches that align with current substance abuse policy, including naloxone kits, drug checking services, and heroin-assisted treatment programmes.

Thistle Facility Shows Declining Usage Patterns

The Glasgow consumption room opened on 13 January 2025 after approval from Glasgow City Integration Joint Board in September 2023. Recent data reveals concerning trends about the facility’s sustainability and effectiveness.

May 2025 figures showed a 13% drop in visits compared to April, falling from 847 to 737 occasions. Injecting episodes also decreased significantly, from 610 in April to 451 in May. These declining numbers raise questions about long-term demand for such services within UK drug policy frameworks.

Since opening, The Thistle has recorded 3,468 total visits with 2,461 injecting episodes. The facility experienced growth through its first quarter, peaking at 864 visits in March before the recent decline began.

Medical Emergencies Highlight Ongoing Risks

Neil Gray, Scotland’s health secretary, reported 35 medical emergencies at the centre since opening. While claiming all users survived these incidents, he acknowledged the serious nature of these events.

“In all cases, the service user has survived to be able to return to the facility,” Gray told the committee. “Although I cannot prove it at this stage, my contention is that, were those service users not within The Thistle, they would not have survived.”

These emergency figures underscore the continued health risks associated with drug use, even under supervised conditions. Critics argue that resources might be better directed towards comprehensive treatment programmes that address addiction’s root causes.

Scotland Considers Further Expansion Despite Westminster Opposition

Gray indicated that other Scottish areas, including Edinburgh, have expressed interest in opening similar facilities. He suggested these could proceed without waiting for The Thistle evaluation to conclude.

“That does not necessitate having to wait until the end of the Glasgow pilot. That could happen before then, but it is for those local areas to come forward with their own proposals,” he said.

This approach directly challenges Westminster’s substance abuse policy by expanding supervised consumption without federal approval. The divergence highlights growing tensions between Scottish and UK approaches to drug intervention.

Evaluation Timeline Creates Policy Uncertainty

Johnson noted that meaningful assessment data won’t be available for two and a half years, creating significant uncertainty about the programme’s effectiveness. “As I understand the evidence that you have received, the interim evaluation will be available in two and a half years’ time,” she told MPs.

This extended timeline complicates policy decisions about future UK drug policy directions. Without comprehensive data, expanding supervised consumption remains contentious among policymakers and communities.

Community Impact Raises Local Concerns

Recent reports describe ongoing problems around The Thistle, including drug debris requiring industrial cleanup efforts on nearby Tobago Street. These community impacts highlight broader questions about how consumption facilities affect neighbourhood safety and public health.

The declining usage figures, combined with persistent local concerns, suggest supervised consumption may not address fundamental issues driving Scotland’s drug crisis. Alternative approaches focusing on prevention and recovery may offer more sustainable solutions.

Westminster Maintains Focus on Treatment and Prevention

The government’s firm stance reflects commitment to addressing drug misuse through established medical and legal channels. Johnson emphasised collaboration with Scotland while maintaining existing legislative frameworks.

“For the UK government, we want to work with the Scottish government in sharing the good practice and looking at what works,” she stated.

This position prioritises long-term recovery and community safety over short-term harm reduction measures. Westminster’s approach suggests UK drug policy will continue emphasising treatment and prevention rather than expanding facilities that accommodate continued substance use.

The Commons Scottish Affairs Committee launched its inquiry to examine The Thistle’s medical effectiveness in reducing drug-related harm. However, early indicators suggest mixed results that may not support broader expansion of supervised consumption across Britain.

Source: dbrecoveryresources